Tratamiento con tocolíticos para el parto prematuro

1 HaasDM, Imperiale TF,KirkpatrickPR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: ameta-analysisanddecisionanalysis.Obstet Gynecol 2009;113:585-94.
2 Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;(3):CD004454.
3 Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2008. Natl Vital Stat Rep 2010;58:1-17.
4 ACOG practice bulletin. Management of preterm labor. No 43, May 2003. Obstet Gynecol 2003;101:1039-47.
5 Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002;100:1020-37
6 Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2006;(3):CD001060.
7 Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S.Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004;(2):CD004352.
8 KingJ, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating Preterm labour. Cochrane Database Syst Rev 2005;(2):CD001992.
9 KingJF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; (1): CD002255.
10 Papatsonis D,FlenadyV, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting Preterm labour. Cochrane Database Syst Rev 2005;(3):CD004452.
11 Caritis SN. Metaanalysis and labor inhibition therapy. Am J Obstet Gynecol 2011;204:95-6.
12 Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence.BMJ 2005; 331:897-900.
13 Caldwell DM, Welton NJ, Ades AE. Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. J Clin Epidemiol 2010; 63:875-82.
14 Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 2009;181:488-93.
15 Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0[updated March2011].Chapter 8.In: The Cochrane Library. Wiley, 2009. www.cochrane-handbook.org.
16 Haas DM, Kirkpatrick PR, McIntosh JJ, Caldwell DM. Assessing the quality of the evidence for preterm labor tocolysis trials. J Matern Fetal Neonatal Med 2012; 25:1646-52.
17 Lu G, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc 2006; 101:447-59.
18 Spiegelhalter D, Thomas A, Best N, Lunn DJ. WinBUGS user manual v1.4. MRC BiostatisticsUnit, 2003.
19 Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373:746-58.
20 Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23:3105-24.
21 Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002;21:2313-24.
22 Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med 2009;28:1861-81.
23 Dakin H, Welton NJ, Ades AE. Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primaryopen-angle glaucoma and ocular hypertension. Stat Med 2011; published on line 5 Jul.
24 Dempster AP. The direct use of likelihood for significance testing. Stat Comput 1997;7:247-52.
25 Dias S, Welton NJ, Sutton AJ, Caldwell DM, Guobing L, Ades AE. NICE DSU technical support document 4: inconsistency in networks of evidence based on randomized controlled trials. 2011.
26 Spiegelhalter DJ, Best NG, Carlin BP, vander Linde A. Bayesian measures of model complexity and fit. JR Stat Soc: Series B Stat Method 2002; 64:583-639.
27 Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N Engl J Med 1992; 327:308-12.
28 Adam GS. Isoxuprine and premature labour. Aust NZ J Obstet Gynaecol 1966; 6:294-8.
29 Cotton DB, Strassner HT, Hill LM, Schifrin BS, Paul RH. Comparison of magnesiumsulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study.J Reprod Med 1984; 29:92-7.
30 Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990; 163:767-72.
31 Csapo AI, Herczeg J. Arrest of premature labor by isoxsuprine. Am J Obstet Gynecol 1977;129:482-91.
32 GoodwinTM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosibanon preterm uterine activity in the human. Am J Obstet Gynecol 1994; 170:474-8.
33 How HY, Zafaranchi L, Stella CL, Recht K, Maxwell RA, Sibai BM, et al. Tocolysis inwomen with preterm labor between32 0/7and34 6/7 weeks of gestation: a randomized controlled pilot study. Am J Obstet Gynecol 2006; 194:976-81.
34 Ingemarsson I. Effect of terbutaline on premature labor. A double-blind placebo-controlled study. Am J Obstet Gynecol 1976; 125:520-4.
35 Larsen JF, Eldon K, Lange AP, Leegaard M, Osler M, Olsen JS, et al. Ritodrine in the treatment of preterm labor: second Danish Multicenter Study. Obstet Gynecol 1986; 67:607-13.
36 Larsen JF, Hansen MK, Hesseldahl H, Kristoffersen K, Larsen PK, Osler M, et al. Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. Br J Obstet Gynaecol 1980; 87:949-57.
37 Leveno KJ, Klein VR, Guzick DS, Young DC, Hankins GD, Williams ML.Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet 1986;1:1293-6.
38 Ma L. [Magnesium sulfate in prevention of preterm labor]. Zhonghua Yi Xue Za Zhi 1992;72:158-61,91.
39 Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. II. Evidence of efficacy. Obstet Gynecol 1980; 56:7-12.
40 Mital P, Garg S, Khuteta RP, Khuteta S, Mital P. Mefenamicacid in prevention of premature labour. J R Soc Health 1992;112:214-6.
41 Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980;136:1014-9.
42 Panter KR, Hannah ME, Amankwah KS, Ohlsson A, Jefferies AL, Farine D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomized placebo-controlled trial. Br J Obstet Gynaecol 1999;106:467-73.
43 Read MD, Wellby DE. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 1986; 93:933-7.
44 Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182:1173-83.
45 Smith GN, Walker MC, Ohlsson A, O’Brien K, Windrim R. Randomized double-blindplacebo-controlled trial of transdermal nitroglycerin for preterm labor. Am J Obstet Gynecol 2007;196:37e1-8.
46 Spellacy WN, Cruz AC, Birk SA, Buhi WC. Treatment of premature labor with ritodrine: a randomized controlled study. Obstet Gynecol 1979; 54:220-3.
47 Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977;129:1-4.
48 Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol 1988;159:216-22.
49 Zuckerman H,Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II double-blind study.J Perinat Med 1984; 12:25-9.
50 Husslein P, Cabero Roura L, Dudenhausen JW, Helmer H, Frydman R, Rizzo N,et al. Atosiban versus usual care for the management of preterm labor. J Perinat Med 2007;35:305-13.
51 ThorntonS, Goodwin TM, Greisen G, Hedegaard M, Arce J-C. The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 2009; 200:627.e1-10.
52 Al-QattanF, Omu AE, Labeeb N. A prospective randomized study comparing nifedipine versus ritodrine for the suppression of preterm labour. Med Princ Pract 2000;9:164-73.
53 Jimenez Aramayo JF,Jimenez Martinez F,Lopez Rosales C.[Tocolytic therapy with Magnesium sulfate and terbutaline for inhibition of premature labor]. Ginecol Obstet Mex 1990; 58:265-9.
54 Treatment of pretermlabor with the oxytocin antagonistat osiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177-85.
55 The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001; 80:413-22.
56 Beall MH,Edgar BW, Paul RH, Smith-WallaceT. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985; 153:854-9.
57 Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991;164:981-6;discussion 86-8.
58 Bisits A, Madsen G, Knox M, Gill A, Smith R, Yeo G, et al. The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor. Am J Obstet Gynecol 2004; 191:683-90.
59 CararachV, Palacio M, Martinez S, Deulofeu P, Sanchez M, Cobo T,et al. Nifedipine versus ritodrine for suppression of preterm labor. Comparison of their efficacy and secondaryeffects. Eur J Obstet Gynecol Reprod Biol 2006; 127:204-8.
60 CaritisSN, Toig G, Heddinger LA, Ashmead G. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 1984; 150:7-14.
61 Chau AC, Gabert HA, Miller JM Jr. A prospective comparison of terbutaline and magnesium for tocolysis. Obstet Gynecol 1992; 80:847-51.
62 Essed GGM, Eskes TKAB, Jongsma HW. A randomized trial of two beta-mimetic drugs for the treatment of threatening early labor: clinical results in a prospective comparative study with ritodrine and fenoterol. Eur J Obstet Gynecol Reprod Biol 1978; 8:341-8.
63 FanL, WuL, Huang X. [The effect of calcium entry blocker on the management of preterm labor—a randomized controlled study]. J Pract Gynecol Obstet 2003;19:87-9.
64 Garcia-Velasco JA, Gonzalez Gonzalez A. A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor. Int J Gynaecol Obstet 1998;61:239-44.
65 Goodwin TM, Valenzuela GJ, Silver H, Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol 1996; 88:331-6.
66 Grignaffini A, Soncini E, Ronzoni E, LoCane F, Anfuso S, Nardelli GB. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor. Minerva Ginecol 2007; 59:481-9.
67 Gummerus M. [Tocolysis with hexoprenalin and salbutamol in a clinical comparison]. Geburtshilfe Frauenheilkd 1983;43:151-5.
68 Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987; 156:631-7.
69 Holleboom CA, Merkus JM, van Elferen LW, Keirse MJ. Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour. Br J Obstet Gynaecol 1996; 103:695-701.
70 Janky E, Leng JJ, Cormier PH, Salamon R, Meynard J.[A randomized study of the treatment of threatened premature labor. Nifedipine versus ritodrine]. J Gynecol Obstet Biol Reprod (Paris) 1990;19:478-82.
71 Jannet D,Abankwa A,Guyard B, Carbonne B, Marpeau L, Milliez J. Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomized study. Eur J Obstet Gynecol Reprod Biol 1997; 73:11-6.
72 Koks CA, Brolmann HA, de Kleine MJ, Manger PA. A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur J Obstet Gynecol Reprod Biol 1998; 77:171-6.
73 Kramer WB, Saade GR, Belfort M, Dorman K, Mayes M, Moise KJ Jr. A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor. Am J Obstet Gynecol 1999; 180:396-401.
74 Kupferminc M, Lessing JB, Yaron Y, Peyser MR. Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol 1993;100:1090-4.
75 Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrinin threatened preterm labor. Obstet Gynecol 1991; 78:1093-7.
76 Laohapojanart N, Soorapan S, Wacharaprechanont T, Ratanajamit C. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor. J Med Assoc Thai 2007;90:2461-9.
77 Lauersen NH, Merkatz IR, Tejani N, Wilson KH, Roberson A, Mann LI, et al. Inhibition of premature labor: a multicenter comparison of ritodrine and ethanol. Am J Obstet Gynecol 1977; 127:837-45.
78 Maitra N, Christian V, Kavishvar A. Tocolytic efficacy of nifedipine versus ritodrine in preterm labor. Int J Gynaecol Obstet 2007; 97:147-8.
79 Mawaldi L, Duminy P, Tamim H. Terbutaline versus nifedipine for prolongation of pregnancy in patients with preterm labor. Int J Gynaecol Obstet 2008; 100:65-8.
80 Miller JM Jr, Keane MW, Horger EO 3rd. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. A preliminary report. J Reprod Med 1982; 27:348-51.
81 Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 1989; 74:567-72.
82 Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000; 182:1191-9.
83 Neri I, Monari F, Valensise H, Vasapollo B, Facchinetti F, Volpe A. Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine. Am J Perinatol 2009; 26:259-63.
84 Papatsonis DN, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997; 90:230-4.
85 Raymajhi R, Pratap K. A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour. Kathmandu Univ Med J (KUMJ) 2003; 1:85-90.
86 Roy UK, Pan S. Use of calcium antagonist (nifedipine) in prematurel abour. J Indian Med Assoc 1993; 91:8-10.
87 Shim JY, Park YW, Yoon BH, Cho YK, Yang JH,Lee Y,et al. Multicentre,parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. BJOG 2006; 113:1228-34.
88 Spearing G. Alcohol, indomethacin, and salbutamol. A comparative trial of their use in preterm labor. Obstet Gynecol 1979; 53:171-4.
89 Surichamorn P. The efficacy of terbutaline and magnesium sulfate in the management of preterm labor. J Med Assoc Thai 2001; 84:98-104.
90 Tchilinguirian NG, Najem R, Sullivan GB, Craparo FJ. The use of ritodrine and magnesium sulfate in the arrest of premature labor. Int J Gynaecol Obstet 1984; 22:117-23.
91 Trabelsi K, Hadj Taib H, Amouri H, Abdennadheur W, Ben Amar H, Kallel W,et al. Nicardipine versus salbutamol in the treatment of premature labor: comparison of their efficacy and side effects. Tunis Med 2008; 86:43-8.
92 Van de Water M, Kessel ET, De Kleine MJ, Oei SG. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial. Acta Obstet Gynecol Scand 2008; 87:340-5.
93 Wang H, Zeng W, Liu H, Ou Y. [A randomized controlled trial on the treatment of preterm labor with ritodrine hydrochloride and magnesium sulfate]. J West China Univ Med Sci 2000; 31:515-7.
94 Weerakul W, Chittacharoen A, Suthutvoravut S. Nifedipine versus terbutaline in management of preterm labor. Int J Gynaecol Obstet 2002; 76:311-3.
95 Wilkins IA, Lynch L, Mehalek KE, Berkowitz GS, Berkowitz RL. Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol 1988; 159:685-9.
96 Zhu B, Fu Y. [Treatment of preterm labor with ritodrine]. Zhonghua Fu Chan Ke Za Zhi 1996; 31:721-3.
97 Lin CH, Lin SY, Shyu MK, Chen SU, Lee CN. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment  of spontaneous preterm labor in Taiwanese women. J Formos Med Assoc 2009; 108:493-501.
98 Motazedian S, Ghaffarpasand F, Mojtahedi K, Asadi N. Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. Ann Saudi Med 2010; 30:370-5.
99 Borna S, Saeidi FM. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial. J Obstet Gynaecol Res 2007; 33:631-4.
100 El-Sayed YY,Riley ET, Holbrook RH Jr, Cohen SE, Chitkara U, Druzin ML. Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor. Obstet Gynecol 1999; 93:79-83.
101 Floyd RC, McLaughlin BN, Perry KG, Martin RW, Sullivan CA, Morrison JC. Magnesium sulfate or nifedipine hydrochloride for acute tocolysis of preterm labor: efficacy and side effects. J Matern Fetal Invest 1995; 5:25-9.
102 Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993; 169:960-4.
103 Haghighi L. Prevention of preterm delivery: nifedipine or magnesium sulfate. Int J Gynaecol Obstet 1999; 66:297-8.
104 Larmon JE, Ross BS, May WL, Dickerson GA, Fischer RG, Morrison JC. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol 1999; 181:1432-7.
105 Lorzadeh N, Kazemirad S, Lorzadrh M, Dehnori A. A comparison of human chorionic gonadotropin with magnesium sulphate in inhibition of preterm labor. J Med Sci 2007; 7:640-4.
106 Lyell DJ, Pullen K, Campbell L, Ching S, Druzin ML, Chitkara U, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol 2007; 110:61-7.
107 McWhorter J, Carlan SJ, OLeary TD, Richichi K, Obrien WF. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial. Obstet Gynecol 2004; 103:923-30.
108  Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186:1111-8.
109 Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of pretermlabor: a randomized study. Am J Obstet Gynecol 1993; 169:97-102.
110 Parilla BV, Tamura RK, Cohen LS, Clark E. Lack of effect of antenatal indomethacin on fetal cerebral blood flow. Am J Obstet Gynecol 1997; 176:1166-9; discussion 69-71.
111 Schorr SJ, Ascarelli MH, Rust OA, Ross EL, Calfee EL, Perry KG Jr, et al. A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor. South Med J 1998; 91:1028-32.
112 Taherian A, Dehdar P. Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labor. J Res Med Sci 2007; 12:136-41.
113 Al-Omari WR, Al-Shammaa HB, Al-Tikriti EM, Ahmed KW. Atosiban and nifedipine in acute tocolysis: a comparative study. Eur J Obstet Gynecol Reprod Biol 2006; 128:129-34.
114 Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet 2005; 91:10-4.
115 Amorim MMR, Lippo LAM, Costa AAR, CoutinhoI C, Souza ASR. [Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial]. Rev 2009; 31:552-8.
116 Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynaecol Obstet 2011; 113:192-5.
117 Nassar AH, Abu-Musa AA, Awwad J, Khalil A, Tabbara J,UstaI M. Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial. Am J Perinatol 2009; 26:575-81.
118 RasanenJ, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol 1995; 173:20-5.
119 Sawdy RJ, Lye S, Fisk NM, Bennett PR. A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. Am J Obstet Gynecol 2003; 188:1046-51.
120  Stika CS, Gross GA, Leguizamon G, Gerber S, Levy R, Mathur A, et al. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 2002; 187:653-60.
121 Macones GA, Bader TJ, Asch DA. Optimising maternal-fetal outcomes in preterm labour: a decision analysis. Br J Obstet Gynaecol 1998; 105:541-50.
122 Groom KM, Shennan AH, Jones BA, Seed P, Bennett PR. TOCOX— a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005; 112:725-30.
123 Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329:1602-7.
124 Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342:1500-7.
125 SekarK C, Corff KE. Treatment of patent ductus arteriosus: indomethacin or ibuprofen? J Perinatol 2008; 28(Suppl1):S60-2.
126 Peckham GJ, Miettinen OS, Ellison RC, Kraybill EN, Gersony WM, Zierler S, et al. Clinical course to 1year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. J Pediatr 1984; 105:285-91.
127 Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326:472.
128 Caldwell DM, Gibb DM, Ades AE. Validity of indirect comparisons in meta-analysis. Lancet 2007; 369:270; authorreply 71.
129 Chou R, Fu R, Huffman LH, Korthuis PT. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet 2006; 368:1503-15.
130 Dias S, Welton NJ, Sutton A, Ades A. NICE DSU technical support document 2: a generalized linear modeling framework for pair-wise and network meta-analysis. Technical support document series No2, 2011.www.nicedsu.org.uk.
131 Caldwell DM. Using mixed treatment comparisons in health technology assessment. University of Bristol, 2008.
132 Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004; 23:1351-75.
133 Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 2007; 26:53-77.
134 Lu G, Ades AE, Sutton AJ, Cooper NJ, Briggs AH, Caldwell DM.Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med 2007; 26:3681-99.
135 Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282:1054-60